1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > 2016-2020 Future Horizons and Growth Strategies in the EU5 Therapeutic Drug Monitoring (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

This new 291-page report from VPGMarketResearch provides a comprehensive analysis of the European therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin.

During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.


This unique market and technology assessment is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.           
      
Contains 291 pages and 61 tables

Table Of Contents

2016-2020 Future Horizons and Growth Strategies in the EU5 Therapeutic Drug Monitoring (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
Introduction
Worldwide Market and Technology Overview
A. Major Therapeutic Drug Monitoring Tests
1. Overview
2. Carbamazepine
3. Cyclosporin
4. Digoxin
5. Everolimus
6. Gentamicin
7. Lamotrigine/Lamictal
8. Levetiracetam
9. Lidocaine
10. Lithium
11. Phenytoin
12. NAPA/Procainamide
13. Quinidine
14. Sirolimus
15. Tacrolimus
16. Topirimate
17. Theophylline
18. Valproic Acid
B. Instrumentation Review: Operating characteristics
and features of high-, medium-, and low-volume/POC
analyzers manufactured by Abaxis, Abbott, Alere/Inverness,
Alfa Wassermann, AMS, Awareness Technologies, Beckman Coulter/Olympus,
Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba,
Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox,
Roche, Siemens, Tosoh, Vital Diagnostics and other suppliers

C. Major In Vitro Diagnostic Technologies
And Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
d. Chemiluminescence
c. Enzyme Immunoassays (EIA)
° Overview
° ELISA
° EMIT
° Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors

France: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares
Germany: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares
Italy: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares
Spain: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares
UK: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares


Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments

- Abbott Laboratories
- AdnaGen/Alere
- Agilent Technologies
- Bayer Healthcare
- Beckman Coulter/Danaher
- Biomedical Diagnostics
- BioMerieux
- Bio-Rad
- DiaSorin
- Eiken
- Fujirebio
- Grifols
- Instrumentation Laboratory

- Kyowa Medex
- Matritech/Alere
- Ortho-Clinical Diagnostics
- Quest Diagnostics
- Roche
- Siemens
- Sysmex
- Thermo Fisher
- Tosoh
- Wako
- Wallac/PE


List of Tables
Major Companies Developing or Marketing
TDM Tests
Major Companies Developing or Marketing
Digoxin Tests
Major Companies Developing or Marketing
Lithium Tests
Major Companies Developing or Marketing
Phenytoin Tests
Major Companies Developing or Marketing
Theophylline Tests
Major Companies Developing or Marketing
Valproic Tests
Major Companies Developing or Marketing
Biosensors for Genetic Disease Testing
France, Laboratories Performing TDM
Tests By Market Segment
France, Hospital Laboratories Performing
TDM Tests By Bed Size
France, Commercial/Private Laboratories
Performing TDM Tests By Annual Test Volume
France, TDM Test Volume Forecast By Market Segment
France, Hospital Laboratories, TDM
Test Volume Forecast by Assay
France, Commercial/Private Laboratories,
TDM Test Volume Forecast by Assay
France, TDM Reagent Market Forecast
By Market Segment

France, Hospital Laboratories, TDM
Diagnostics Market Forecast by Assay
France, Commercial/Private Laboratories,
TDM Diagnostics Market Forecast by Assay
France, Major Suppliers of Immunodiagnostic Products,
Estimated Market Shares
Germany, Laboratories Performing TDM
Tests By Market Segment
Germany, Hospital Laboratories Performing
TDM Tests By Bed Size
Germany, Commercial/Private Laboratories
Performing TDM Tests By Annual Test Volume

Germany, TDM Test Volume Forecast By Market
Segment
Germany, Hospital Laboratories, TDM
Test Volume Forecast by Assay
Germany, Commercial/Private Laboratories,
TDM Test Volume Forecast by Assay
Germany, Physician Offices/Group
Practices, TDM Test Volume Forecast by Assay

Germany, TDM Reagent Market Forecast
By Market Segment

Germany, Hospital Laboratories, TDM
Reagent Market Forecast by Assay
Germany, Commercial/Private Laboratories,
TDM Reagent Market Forecast by Assay
Germany, Physician Offices/Group
Practices, TDM Reagent Market Forecast by Assay

Germany, Major Suppliers of Immunodiagnostic Products,
Estimated Market Shares
Italy, Laboratories Performing TDM
Tests By Market Segment
Italy, Hospital Laboratories Performing
TDM Tests By Bed Size
Italy, Commercial/Private Laboratories
Performing TDM Tests By Annual Test Volume
Italy, TDM Test Volume Forecast
By Market Segment
Italy, Hospital Laboratories, TDM
Test Volume Forecast by Assay
Italy, Commercial/Private Laboratories,
TDM Test Volume Forecast by Assay
Italy, TDM Reagent Market Forecast
By Market Segment
Italy, Hospital Laboratories, TDM
Reagent Market Forecast by Assay
Italy, Commercial/Private Laboratories,
TDM Reagent Market Forecast by Assay
Italy, Major Suppliers of Immunodiagnostic Products,
Estimated Market Shares
Spain, Laboratories Performing TDM
Tests By Market Segment
Spain, Hospital Laboratories Performing
TDM Tests By Bed Size
Spain, Commercial/Private Laboratories
Performing TDM Tests By Annual Test Volume

Spain, TDM Test Volume Forecast
By Market Segment
Spain, Hospital Laboratories, TDM
Test Volume Forecast by Assay
Spain, Commercial/Private Laboratories,
TDM Test Volume Forecast by Assay
Spain, Ambulatory Care Centers,
TDM Test Volume Forecast by Assay
Spain, All Market Segments, TDM
Reagent Market Forecast by Assay
Spain, Hospital Laboratories, TDM
Reagent Market Forecast by Assay
Spain, Commercial/Private Laboratories,
TDM Reagent Market Forecast by Assay
Spain, Ambulatory Care Centers,
TDM Reagent Market Forecast by Assay
Spain, Major Suppliers of Immunodiagnostic Products,
Estimated Market Shares
U.K., Laboratories Performing TDM
Tests By Market Segment
U.K., Hospital Laboratories Performing
TDM Tests By Bed Size
U.K., Commercial/Private Laboratories
Performing TDM Tests By Annual Test Volume
U.K., TDM Test Volume Forecast
By Market Segment

U.K., Hospital Laboratories, TDM
Test Volume Forecast by Assay
U.K., Commercial/Private Laboratories,
TDM Test Volume Forecast by Assay
U.K., TDM Reagent Market Forecast
By Market Segment
U.K., Hospital Laboratories, TDM
Reagent Market Forecast by Assay
U.K., Commercial/Private Laboratories,
TDM Reagent Market Forecast by Assay
U.K., Major Suppliers of Immunodiagnostic Products,
Estimated Market Shares

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.